Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Mologic Ltd. is currently managing a patent portfolio in the Chemistry & Materials technology area. The company has 2 pending office actions, which are distributed across 2 distinct examiners. This distribution suggests that the prosecution workload is not concentrated, requiring the applicant to manage multiple different examiner perspectives simultaneously. Because the cases are also spread across 2 distinct art units, the legal strategy must account for the varying procedural nuances of different specialized groups.
The busiest examiner for this portfolio is SIEFKE, SAMUEL P, who is responsible for 1 busiest_examiner_pending office action. Since this examiner only handles a portion of the workload, there is no primary point of contact for the company's chemistry filings. Instead, the applicant must maintain a broad approach to address the specific requirements of each individual examiner involved in the 1 pending matter they oversee.
For a patent practitioner, this fragmented landscape means that successes or setbacks in one case may not necessarily predict outcomes in others. The lack of overlap among the distinct examiners and art units indicates a diverse array of technical subject matter. Managing the 2 pending office actions will require a tailored response for each examiner, including SIEFKE, SAMUEL P, to ensure consistent progress across the entire portfolio.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §102 only | 1 (50%) |
| §112 only | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SIEFKE, SAMUEL P | 1 | 63.0% | +17.8% |
| KIRWIN, STEFANIE JOHANNA | 1 | 15.6% | +29.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17263449 | BACTERIAL VAGINOSIS DIAGNOSTIC | KIRWIN, STEFANIE JOHANNA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18015797 | LATERAL FLOW DEVICE | SIEFKE, SAMUEL P | — |
| 17263449 | BACTERIAL VAGINOSIS DIAGNOSTIC | KIRWIN, STEFANIE JOHANNA | — |
| Art Unit | Apps |
|---|---|
| 1758 | 1 |
| 1677 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18015797 | LATERAL FLOW DEVICE | SIEFKE, SAMUEL P | 1758 | §102 | Non-Final OA | — | Pending | Jan 12, 2023 |
| 17263449 | BACTERIAL VAGINOSIS DIAGNOSTIC | KIRWIN, STEFANIE JOHANNA | 1677 | §112 | Final Rejection | — | Pending | Jan 26, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialMologic Ltd. has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Samuel P Siefke has the most, with 1 of Mologic Ltd.'s pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
